Eric Broyles

Eric Broyles is a seasoned entrepreneur and legal expert with extensive experience in the biotechnology and litigation support industries. As Founder and CEO of Nanocan Therapeutics Corporation since 2020, Eric leads the development of innovative nanotechnology-based therapies for cancer treatment. In addition, Eric founded ExpertConnect Litigation Support, LLC in 2018, providing essential services for law firms and corporations to secure expert witnesses. Eric also serves on the Board of Trustees of the University of Cincinnati Foundation, is a board member at Universal PharmaSystems, Inc., and has held various leadership positions, including co-founding megree, Inc. and founding ExpertConnect. Prior legal experience includes positions at Gerson Lehrman Group, AOL, and Skadden, Arps, Slate, Meagher & Flom LLP. Eric holds a Juris Doctor from the University of Virginia School of Law and a BBA from the University of Cincinnati.